CV Sciences (CVSI) News Today $0.05 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Advanced sampling method can track dynamic evolution of protein foldingNovember 3 at 10:00 AM | msn.comCV Sciences Inc (CVSI) Q2 2024 Earnings Call Highlights: Strategic Moves and Financial ...October 9, 2024 | finance.yahoo.comCV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free SupplementsAugust 27, 2024 | prnewswire.comHemp-Focused CV Sciences Reports Flat Revenue And Over 8% YoY Increase In Gross Profit In Q2August 13, 2024 | msn.comCV Sciences, Inc. (CVSI) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | seekingalpha.comCV Sciences, Inc. Reports Second Quarter 2024 Financial ResultsAugust 13, 2024 | prnewswire.comCV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024August 7, 2024 | prnewswire.comCV Sciences, Inc. (CVSI)May 15, 2024 | finance.yahoo.comCV Sciences Inc (CVSI) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ...May 15, 2024 | finance.yahoo.comHemp-Focused CV Sciences Reports Steady Q1 Revenue Amid Operational Hurdles And Acquisition Of Nutraceuticals ManufacturerMay 14, 2024 | msn.comCVSI Stock Earnings: CV Sciences Reported Results for Q1 2024May 14, 2024 | investorplace.comCV Sciences, Inc. Reports First Quarter 2024 Financial ResultsMay 14, 2024 | prnewswire.comCV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURERMay 13, 2024 | prnewswire.comCV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024May 8, 2024 | prnewswire.comCV Sciences, Inc. (PNK:CVSI) Q4 2023 Earnings Call TranscriptApril 1, 2024 | finance.yahoo.comCVSI Stock Earnings: CV Sciences Reported Results for Q4 2023March 28, 2024 | investorplace.comCV Sciences, Inc. Reports Fiscal Year-End 2023 Financial ResultsMarch 28, 2024 | prnewswire.comCV Sciences Inc.March 27, 2024 | wsj.comCV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet ChewsMarch 26, 2024 | finance.yahoo.comCV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024March 21, 2024 | prnewswire.comCV Sciences Stock (OTC:CVSI), Short Interest ReportFebruary 22, 2024 | benzinga.comCV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European DistributionDecember 12, 2023 | finance.yahoo.comThe Best Shampoo for Thinning Hair We Tested Is 30% Off Right NowNovember 15, 2023 | nz.finance.yahoo.comCV Sciences, Inc. (PNK:CVSI) Q3 2023 Earnings Call TranscriptNovember 15, 2023 | finance.yahoo.comHemp-Focused Wellness Company: Revenue Jumps To $4.1M, Gross Margin Peaks At 45.1%November 14, 2023 | benzinga.comCV Sciences GAAP EPS of $0.00, revenue of $4.09MNovember 14, 2023 | msn.comCV Sciences, Inc. Reports Third Quarter 2023 Financial ResultsNovember 14, 2023 | finance.yahoo.comCV Sciences Inc CVSINovember 12, 2023 | morningstar.comCV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023November 9, 2023 | finance.yahoo.comCV Sciences, Inc. Launches Reserve Sleep GummiesSeptember 5, 2023 | finance.yahoo.comCV Sciences, Inc. (PNK:CVSI) Q2 2023 Earnings Call TranscriptAugust 15, 2023 | finance.yahoo.comCV Sciences GAAP EPS of -$0.01, revenue of $4MAugust 14, 2023 | seekingalpha.comPublicly Traded Hemp-Focused Wellness Company Reports Q2 Results, Here Is What You Need To KnowAugust 14, 2023 | benzinga.comCV Sciences, Inc. Reports Second Quarter 2023 Financial ResultsAugust 14, 2023 | finance.yahoo.comCV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023August 1, 2023 | finance.yahoo.comCVSI - CV Sciences, Inc.July 8, 2023 | finance.yahoo.comCV Sciences to Participate in LD Micro Invitational ConferenceJune 1, 2023 | finance.yahoo.comCV Sciences Inc Q1 Revenue Stagnates YoY, Here Is What You Need To KnowMay 15, 2023 | msn.comCV Sciences, Inc. Reports First Quarter 2023 Financial ResultsMay 15, 2023 | finance.yahoo.comCV Sciences earnings: here's what Wall Street expectsMay 14, 2023 | markets.businessinsider.comCV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023May 9, 2023 | finance.yahoo.comCV Sciences, Inc. (PNK:CVSI) Q4 2022 Earnings Call TranscriptApril 9, 2023 | finance.yahoo.comCV Sciences, Inc. Introduces New THC OfferingApril 3, 2023 | finance.yahoo.comCV Sciences FY22 Revenue Declines 19% To $16.2MMarch 29, 2023 | msn.comCV Sciences, Inc. Reports Fiscal Year-End 2022 Financial ResultsMarch 29, 2023 | finance.yahoo.comCV Sciences is about to announce its earnings — here's what to expectMarch 28, 2023 | markets.businessinsider.comCV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023March 25, 2023 | finance.yahoo.comCV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco AddictionMarch 23, 2023 | finance.yahoo.comCV Sciences, Inc. Launches New Line of THC-Free Gummies and SoftgelsMarch 21, 2023 | finance.yahoo.comCV Sciences, Inc. Announces Proposed Settlement of Shareholder LitigationMarch 4, 2023 | benzinga.com Get CV Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CVSI and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. CVSI Media Mentions By Week CVSI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CVSI News Sentiment▼0.760.46▲Average Medical News Sentiment CVSI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CVSI Articles This Week▼10▲CVSI Articles Average Week Get CV Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CVSI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ESLA News ITRM News LIAN News CELU News ACST News GLYC News DYAI News ACXP News ENLV News LEXX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CVSI) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CV Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CV Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CVSI Stock Alerts